Connect Biopharma Holdings Limited (CNTB) Operating income 2023–2025
Connect Biopharma Holdings Limited (CNTB) annual operating income history from SEC filings — each fiscal year as reported.
-$58.1MFY2025 · since FY2023: -$69.1M → -$58.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$58.1M | -158.7% |
| FY2024 | -$22.5M | +67.5% |
| FY2023 | -$69.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CNTB financial trends
CNTB RevenueCNTB Net incomeCNTB Net marginCNTB Gross profitCNTB Gross marginCNTB Operating marginCNTB Operating cash flowCNTB Free cash flowCNTB Capital expendituresCNTB Return on equityCNTB Stock buybacksCNTB Dividends paidCNTB Total assetsCNTB Total liabilitiesCNTB Shareholders’ equityCNTB overview →